VERNON W ANTHONY — SEC Form 4 filings
SEC reporting owner CIK 1369091. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-19 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 4,908 shares, $86,807 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 2,945 shares @ $15.77 ($46,445) in NovoCure Ltd, filed 2026-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NovoCure Ltd (NVCR) | Director | 6 | — | 3 legs · 4,908 sh · $86,807 | 8 |
| MCCORMICK & CO INC (MKC) | Director | 5 | — | — | 9 |
| Nuvation Bio Inc. (NUVB) | Director | 3 | — | — | 3 |
Form 4 filings — VERNON W ANTHONY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-05-26 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 123,397 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | NovoCure Ltd (NVCR) | Option exercise (M): 21,500 @ $11.39 · Option exercise (M): 21,500 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | MCCORMICK & CO INC (MKC) | Option exercise (M): 2,222 · Option exercise (M): 2,222 (derivative) | EDGAR |
| 2025-06-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 11,215 @ $0 · Grant/award (A): 16,697 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 999 @ $17.35 | EDGAR |
| 2025-05-23 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 292,983 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | MCCORMICK & CO INC (MKC) | Option exercise (M): 1,344 @ $0 · Option exercise (M): 1,344 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | MCCORMICK & CO INC (MKC) | Grant/award (A): 2,222 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 200,801 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | NovoCure Ltd (NVCR) | Sale (S): 964 @ $23.89 · Grant/award (A): 4,053 @ $0 · Grant/award (A): 6,229 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | MCCORMICK & CO INC (MKC) | Grant/award (A): 1,344 (derivative) @ $0 · Grant/award (A): 3,732 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | MCCORMICK & CO INC (MKC) | Option exercise (M): 1,255 · Option exercise (M): 1,255 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1369091 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →